Annual Cash & Cash Equivalents
$2.53 M
-$3.53 M-58.25%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual cash & cash equivalents is $2.53 million, with the most recent change of -$3.53 million (-58.25%) on April 30, 2024.
- During the last 3 years, IPA annual cash & cash equivalents has fallen by -$31.48 million (-92.56%).
- IPA annual cash & cash equivalents is now -92.56% below its all-time high of $34.01 million, reached on April 30, 2021.
Performance
IPA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.54 M
-$284.20 K-10.06%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly cash and cash equivalents is $2.54 million, with the most recent change of -$284.20 thousand (-10.06%) on October 31, 2024.
- Over the past year, IPA quarterly cash and cash equivalents has dropped by -$284.20 thousand (-10.06%).
- IPA quarterly cash and cash equivalents is now -92.53% below its all-time high of $34.01 million, reached on April 30, 2021.
Performance
IPA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IPA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.3% | -10.1% |
| 3 y3 years | -92.6% | -10.1% |
| 5 y5 years | -37.8% | -10.1% |
IPA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.6% | at low | -90.2% | +0.4% |
| 5 y | 5-year | -92.6% | +35.9% | -92.5% | +73.2% |
| alltime | all time | -92.6% | >+9999.0% | -92.5% | >+9999.0% |
ImmunoPrecise Antibodies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $2.54 M(-10.1%) |
| Jul 2024 | - | $2.83 M(+11.6%) |
| Apr 2024 | $2.53 M(-58.3%) | $2.53 M(-45.3%) |
| Jan 2024 | - | $4.63 M(+6.4%) |
| Oct 2023 | - | $4.35 M(-14.3%) |
| Jul 2023 | - | $5.08 M(-16.3%) |
| Apr 2023 | $6.06 M(-73.8%) | $6.06 M(-28.3%) |
| Jan 2023 | - | $8.46 M(-23.5%) |
| Oct 2022 | - | $11.07 M(-25.5%) |
| Jul 2022 | - | $14.85 M(-35.9%) |
| Apr 2022 | $23.15 M(-31.9%) | $23.15 M(-10.4%) |
| Jan 2022 | - | $25.85 M(-16.5%) |
| Oct 2021 | - | $30.95 M(-5.1%) |
| Jul 2021 | - | $32.62 M(-4.1%) |
| Apr 2021 | $34.01 M(+1727.0%) | $34.01 M(+176.6%) |
| Jan 2021 | - | $12.30 M(-2.7%) |
| Oct 2020 | - | $12.64 M(+179.8%) |
| Jul 2020 | - | $4.52 M(+142.7%) |
| Apr 2020 | $1.86 M(-54.2%) | $1.86 M(+26.9%) |
| Jan 2020 | - | $1.47 M(-34.8%) |
| Oct 2019 | - | $2.25 M(-40.2%) |
| Jul 2019 | - | $3.77 M(-7.4%) |
| Apr 2019 | $4.07 M(+189.2%) | $4.07 M(-24.9%) |
| Jan 2019 | - | $5.42 M(-19.5%) |
| Oct 2018 | - | $6.73 M(+271.4%) |
| Jul 2018 | - | $1.81 M(+28.9%) |
| Apr 2018 | $1.41 M(-25.7%) | $1.41 M(-5.6%) |
| Jan 2018 | - | $1.49 M(-15.3%) |
| Oct 2017 | - | $1.76 M(+72.7%) |
| Jul 2017 | - | $1.02 M(-46.1%) |
| Apr 2017 | $1.89 M(>+9900.0%) | $1.89 M(-25.4%) |
| Jan 2017 | - | $2.54 M(+544.0%) |
| Sep 2016 | - | $393.70 K(>+9900.0%) |
| Jun 2016 | - | $1000.00(+400.0%) |
| Mar 2016 | - | $200.00(-66.7%) |
| Dec 2015 | $600.00(-81.8%) | - |
| Dec 2015 | - | $600.00(+50.0%) |
| Sep 2015 | - | $400.00(-81.8%) |
| Jun 2015 | - | $2200.00(+450.0%) |
| Mar 2015 | - | $400.00(-87.9%) |
| Dec 2014 | $3300.00(-91.3%) | - |
| Dec 2014 | - | $3300.00(-8.3%) |
| Sep 2014 | - | $3600.00(-93.1%) |
| Jun 2014 | - | $52.50 K(+971.4%) |
| Mar 2014 | - | $4900.00(-87.1%) |
| Dec 2013 | $38.10 K(+166.4%) | - |
| Dec 2013 | - | $38.10 K(-37.3%) |
| Sep 2013 | - | $60.80 K(+913.3%) |
| Jun 2013 | - | $6000.00(+1400.0%) |
| Mar 2013 | - | $400.00(-97.2%) |
| Dec 2012 | $14.30 K(-21.4%) | - |
| Dec 2012 | - | $14.30 K(+37.5%) |
| Sep 2012 | - | $10.40 K(-50.9%) |
| Jun 2012 | - | $21.20 K(+37.7%) |
| Mar 2012 | - | $15.40 K(-15.4%) |
| Dec 2011 | $18.20 K(-78.1%) | - |
| Dec 2011 | - | $18.20 K(-20.2%) |
| Sep 2011 | - | $22.80 K(-34.1%) |
| Jun 2011 | - | $34.60 K(-39.6%) |
| Mar 2011 | - | $57.30 K(-31.0%) |
| Dec 2010 | $83.10 K | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | - | $83.10 K(+253.6%) |
| Sep 2010 | - | $23.50 K(+56.7%) |
| Jun 2010 | - | $15.00 K(-74.8%) |
| Mar 2010 | - | $59.60 K(-42.1%) |
| Dec 2009 | $103.00 K(-60.2%) | - |
| Dec 2009 | - | $103.00 K(+5.3%) |
| Sep 2009 | - | $97.80 K(-16.2%) |
| Jun 2009 | - | $116.70 K(+5.7%) |
| Mar 2009 | - | $110.40 K(-57.4%) |
| Dec 2008 | $258.90 K(+29.6%) | - |
| Dec 2008 | - | $258.90 K(-58.7%) |
| Sep 2008 | - | $626.40 K(+1276.7%) |
| Jun 2008 | - | $45.50 K(-67.5%) |
| Mar 2008 | - | $140.00 K(-29.9%) |
| Dec 2007 | $199.80 K(-35.3%) | - |
| Dec 2007 | - | $199.80 K(-23.8%) |
| Sep 2007 | - | $262.20 K(-19.7%) |
| Jun 2007 | - | $326.50 K(+278.8%) |
| Mar 2007 | - | $86.20 K(-72.1%) |
| Dec 2006 | $308.70 K(-45.0%) | - |
| Dec 2006 | - | $308.70 K(-50.8%) |
| Sep 2006 | - | $626.90 K(-62.7%) |
| Jun 2006 | - | $1.68 M(+321.6%) |
| Mar 2006 | - | $398.50 K(-29.0%) |
| Dec 2005 | $561.40 K(-73.4%) | - |
| Dec 2005 | - | $561.40 K(-48.6%) |
| Sep 2005 | - | $1.09 M(-34.2%) |
| Jun 2005 | - | $1.66 M(-13.9%) |
| Mar 2005 | - | $1.93 M(-8.7%) |
| Dec 2004 | $2.11 M(+413.0%) | - |
| Dec 2004 | - | $2.11 M(+243.1%) |
| Sep 2004 | - | $615.00 K(-24.9%) |
| Jun 2004 | - | $818.50 K(-9.1%) |
| Mar 2004 | - | $900.00 K(+118.8%) |
| Dec 2003 | $411.30 K(+5860.9%) | - |
| Dec 2003 | - | $411.30 K(+31.5%) |
| Sep 2003 | - | $312.70 K(+1830.2%) |
| Jun 2003 | - | $16.20 K(-54.1%) |
| Mar 2003 | - | $35.30 K(+411.6%) |
| Dec 2002 | $6900.00(-58.7%) | - |
| Dec 2002 | - | $6900.00(-74.8%) |
| Sep 2002 | - | $27.40 K(-58.7%) |
| Jun 2002 | - | $66.30 K(+276.7%) |
| Mar 2002 | - | $17.60 K(+5.4%) |
| Dec 2001 | $16.70 K(-68.1%) | - |
| Dec 2001 | - | $16.70 K(-7.2%) |
| Sep 2001 | - | $18.00 K(-46.7%) |
| Jun 2001 | - | $33.80 K(+31.0%) |
| Mar 2001 | - | $25.80 K(-50.7%) |
| Dec 2000 | $52.30 K(-19.3%) | - |
| Dec 2000 | - | $52.30 K(+730.2%) |
| Sep 2000 | - | $6300.00(-53.0%) |
| Jun 2000 | - | $13.40 K(-59.6%) |
| Mar 2000 | - | $33.20 K(-48.8%) |
| Dec 1999 | $64.80 K(-75.4%) | - |
| Dec 1999 | - | $64.80 K(-75.4%) |
| Dec 1998 | $263.50 K(-57.2%) | - |
| Dec 1998 | - | $263.50 K(-57.2%) |
| Dec 1997 | $616.10 K(+135.5%) | - |
| Dec 1997 | - | $616.10 K |
| Dec 1996 | $261.60 K | - |
FAQ
- What is ImmunoPrecise Antibodies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual cash & cash equivalents year-on-year change?
- What is ImmunoPrecise Antibodies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly cash and cash equivalents year-on-year change?
What is ImmunoPrecise Antibodies annual cash & cash equivalents?
The current annual cash & cash equivalents of IPA is $2.53 M
What is the all time high annual cash & cash equivalents for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual cash & cash equivalents is $34.01 M
What is ImmunoPrecise Antibodies annual cash & cash equivalents year-on-year change?
Over the past year, IPA annual cash & cash equivalents has changed by -$3.53 M (-58.25%)
What is ImmunoPrecise Antibodies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IPA is $2.54 M
What is the all time high quarterly cash and cash equivalents for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly cash and cash equivalents is $34.01 M
What is ImmunoPrecise Antibodies quarterly cash and cash equivalents year-on-year change?
Over the past year, IPA quarterly cash and cash equivalents has changed by -$284.20 K (-10.06%)